InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: zoriden post# 8132

Tuesday, 01/21/2014 3:00:01 PM

Tuesday, January 21, 2014 3:00:01 PM

Post# of 48316
Some cancer tumors are more refractory than others. A combination of Electroporation plus IL-12 plus anti-PD-1 is expected to increase the tumor destruction percentage as well as produce more advanced NK cells for local and systemic responses.

Any of three Majors are possibility partners.

For itself OncoSec has stated as a 2014 milestone is initiation of a 4th solid tumor treatment.